Bile Acid Receptor Agonists in Primary Biliary Cholangitis: Regulation of the Cholangiocyte Secretome and Downstream T Cell Differentiation

FASEB BioAdvances
doi 10.1096/fba.2018-00046
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Emperipolesis Mediated by CD8+ T Cells Correlates With Biliary Epithelia Cell Injury in Primary Biliary Cholangitis

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Cost Effectiveness of Using Ursodeoxycholic Acid to Treat Primary Biliary Cholangitis

British journal of hospital medicine (London, England : 2005)
Medicine
2018English

New Developments in the Treatment of Primary Biliary Cholangitis &Ndash; Role of Obeticholic Acid

Therapeutics and Clinical Risk Management
2017English

Genetics and Epigenetics in the Pathogenesis of Primary Biliary Cholangitis

Clinical Journal of Gastroenterology
MedicineGastroenterology
2017English

microRevolution in Understanding Primary Biliary Cholangitis Pathophysiology

Hepatology
MedicineHepatology
2018English

Abnormal Expression of ERα in Cholangiocytes of Patients With Primary Biliary Cholangitis Mediated Intrahepatic Bile Duct Inflammation

Frontiers in Immunology
AllergyImmunology
2019English

Changing Nomenclature for PBC From “Primary Biliary Cirrhosis” to “Primary Biliary Cholangitis”

Journal of Gastroenterology
Gastroenterology
2016English

Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis

Journal of Immunology Research
MedicineAllergyImmunology
2017English

Primary Biliary Cholangitis: From Diagnosis to Treatment

Annals of Gastroenterology and the Digestive System
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy